By: Emily Yu The National Association of Attorneys General (NAAG) hosted its yearly Capital Forum in Washington, D.C. between December 8 and 10, 2025.  Panels touched on new developments in technology and longstanding areas of AG interest alike, but all centered around goods and services consumed by nearly every American. Social Media and AI Hawaii…

Read More

West Virginia AG J.B. McCuskey, assisted by private outside counsel, filed a federal lawsuit against Optum Inc., United Healthcare’s pharmacy benefit manager, and several affiliated entities, alleging that Optum exacerbated the opioid epidemic in West Virginia through business practices that are unlawful under the West Virginia Consumer Credit and Protection Act and the federal Racketeer…

Read More

Oklahoma AG Gentner Drummond announced a $32.1 million settlement with CVS Caremark to resolve allegations that the company failed to pass along rebates and discounts from drug manufacturers to Oklahoma’s state employee health plan, as required under its contract. Under the terms of the settlement, CVS Caremark must also pay any additional rebate amounts from…

Read More

A group of 21 Republican AGs sent a letter to the U.S. Drug Enforcement Administration requesting emergency action to schedule bromazolam under the Controlled Substances Act. The letter describes bromazolam—an unregulated benzodiazepine that is often referred to as “designer Xanax”—as “highly potent and unpredictable” and “particularly lethal for unsuspecting users” because of its unregulated status,…

Read More

Texas AG Ken Paxton has sued pharmaceutical manufacturer Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe and continue prescribing several Lilly drugs—including GLP-1 medications Mounjaro and Zepbound—in violation of the Texas Health Care Program Fraud Prevention Act. According to the complaint, Eli Lilly offered improper incentives to medical providers in Texas—such…

Read More